Other equities research analysts have also recently issued reports about the stock. Mizuho reiterated a hold rating and issued a $16.00 target price on shares of Wabash National in a research report on Friday, March 1st. Zacks Investment Research cut shares of Zynerba Pharmaceuticals from a buy rating to a hold rating in a research report on Saturday, May 11th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the stock. Wabash National has a consensus rating of Hold and a consensus price target of $19.50.
Shares of WNC stock traded down $0.03 during trading hours on Wednesday, hitting $15.10. The company’s stock had a trading volume of 299,811 shares, compared to its average volume of 404,734. The company has a debt-to-equity ratio of 1.04, a quick ratio of 1.08 and a current ratio of 1.80. The stock has a 50 day simple moving average of $15.06. Wabash National has a 12-month low of $12.25 and a 12-month high of $20.78. The stock has a market cap of $838.66 million, a PE ratio of 10.49 and a beta of 2.02.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 25th. Stockholders of record on Wednesday, July 3rd will be given a dividend of $0.08 per share. The ex-dividend date of this dividend is Tuesday, July 2nd. This represents a $0.32 annualized dividend and a dividend yield of 2.12%. Wabash National’s dividend payout ratio is presently 22.22%.
Institutional investors and hedge funds have recently modified their holdings of the company. Geode Capital Management LLC lifted its position in shares of Wabash National by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 596,564 shares of the company’s stock worth $7,802,000 after purchasing an additional 14,797 shares in the last quarter. O Shaughnessy Asset Management LLC raised its holdings in Wabash National by 104.1% in the first quarter. O Shaughnessy Asset Management LLC now owns 12,878 shares of the company’s stock valued at $174,000 after acquiring an additional 6,567 shares in the last quarter. Mackay Shields LLC acquired a new stake in Wabash National in the fourth quarter valued at approximately $700,000. Stone Ridge Asset Management LLC acquired a new stake in Wabash National in the fourth quarter valued at approximately $233,000. Finally, Metropolitan Life Insurance Co. NY raised its holdings in Wabash National by 340.1% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 18,076 shares of the company’s stock valued at $236,000 after acquiring an additional 13,969 shares in the last quarter. 97.13% of the stock is currently owned by institutional investors and hedge funds.
Wabash National Company Profile
Wabash National Corporation designs, manufactures, and distributes transportation and diversified industrial products; and provides services primarily in the United States. The company operates through three segments: Commercial Trailer Products, Diversified Products, and Final Mile Products. The Commercial Trailer Products segment provides dry van trailers; platform trailers; refrigerated trailers; converter dollies, big tire haulers, steel coil haulers, and RoadRailer trailers; aftermarket parts and services; and used trailers.
Recommended Story: Why do corrections happen?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Wabash National Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wabash National and related companies with MarketBeat.com's FREE daily email newsletter.